The effect of the two drugs( Sodium Thiopental or Etomidate) duration and after ECT

Comparison of recovery time and complications during the use of Etomidate and Thiopental in children under the ECT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016092826950N2

Enrollment

Registered

2016-10-31

Start date

2016-10-11

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Sodium Thiopental. Condition 2: Etomidate. Poisoning:Intravenous anaesthetics Other and unspecified general anaesthetics

Interventions

Intervention 1: First group received A packages included Succinylcholine (0.5 mg/kg) and Sodium thiopental (2 mg/kg). Drugs inject IV and bolusly. Intervention 2: Second group received B packages incl

Treatment - Drugs

First group received A packages included Succinylcholine (0.5 mg/kg) and Sodium thiopental (2 mg/kg). Drugs inject IV and bolusly.

Second group received B packages included Succinylcholine (0.5 mg/kg) and Etomidate (0.1mg/kg). Drugs inject IV and bolusly

Eligibility

Sex/Gender

All

Age

5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the study : All candidates receive Electroconvulsive therapy seizures , of both sexes , age under 18 years , physical status class (ASAI) ; criteria of inclusion: Addiction to alcohol and drugs , age 5 years and older than 18 years , the physical condition of class II patients (A??) above , a history of seizures or epilepsy , brain injury or tumor exclusion criteria : cardio respiratory arrest , requiring intubation and cardiopulmonary resuscitation needs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood Pressure. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: mmhg with Manometer.;Pulse. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: Beat per minute with Pulse Oximeter.;O2 saturation. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: Percent with Pulse Oximeter.;Recovery Duration. Timepoint: From the end of seizure to full consciousness. Method of measurement: Minute with Timer.;Seizure Duration. Timepoint: From the start to the end of seizure. Method of measurement: Second with Timer.;Back to Breathe Spontaneously. Timepoint: From the end of seizure to respiration. Method of measurement: Second with Timer.	—

Measure

Time frame

Blood Pressure. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: mmhg with Manometer.;Pulse. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: Beat per minute with Pulse Oximeter.;O2 saturation. Timepoint: Before injection At 1, 5 and 10 after the shock between the two. Method of measurement: Percent with Pulse Oximeter.;Recovery Duration. Timepoint: From the end of seizure to full consciousness. Method of measurement: Minute with Timer.;Seizure Duration. Timepoint: From the start to the end of seizure. Method of measurement: Second with Timer.;Back to Breathe Spontaneously. Timepoint: From the end of seizure to respiration. Method of measurement: Second with Timer.

—

Secondary

Measure	Time frame
Headache. Timepoint: After recovery. Method of measurement: Ask the patient.;Cough. Timepoint: After recovery. Method of measurement: Ask the patient.;Laryngospasm. Timepoint: After recovery. Method of measurement: Evaluation of patient such as breathing and o2 sat.;Nausea and Vomiting. Timepoint: After recovery. Method of measurement: Ask the patient.;Muscle Pain. Timepoint: After recovery. Method of measurement: Ask the patient.;Pain at injection site. Timepoint: During injection. Method of measurement: Ask the patient.;Myoclonus. Timepoint: From the time of injection until after seizure. Method of measurement: Observation of Complication.	—

Measure

Time frame

Headache. Timepoint: After recovery. Method of measurement: Ask the patient.;Cough. Timepoint: After recovery. Method of measurement: Ask the patient.;Laryngospasm. Timepoint: After recovery. Method of measurement: Evaluation of patient such as breathing and o2 sat.;Nausea and Vomiting. Timepoint: After recovery. Method of measurement: Ask the patient.;Muscle Pain. Timepoint: After recovery. Method of measurement: Ask the patient.;Pain at injection site. Timepoint: During injection. Method of measurement: Ask the patient.;Myoclonus. Timepoint: From the time of injection until after seizure. Method of measurement: Observation of Complication.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Behzad Nazemroaya

Children Psychiatric Ward of Medical Center Al-Zahra

behzad_nazem@med.mui.ac.ir+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026